Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium

Tapas Nayak,Adrian Chrastina,Jose Valencia,Robert Yedidsion,Tim Buss,Brittany Cederstrom,Jim Koziol,Michael D Levin,Bogdan Olenyuk,Jan E Schnitzer

DOI: https://doi.org/10.1101/2024.09.01.610705

2024-09-03

Abstract:Modern medicine seeks precision targeting, imaging and therapy to maximize efficacy and avoid toxicities. Nanoparticles (NPs) have tremendous, yet unmet clinical potential to carry and deliver imaging and therapeutic agents systemically with tissue precision. But their size contributes to unwanted rapid scavenging by the reticulo-endothelial system (RES) and poor penetration of key endothelial cell (EC) barriers, both limiting target-tissue uptake, safety and efficacy. Here, we discover the extraordinary yet size-dependent ability of the EC caveolae pumping system (CPS) to deliver NPs rapidly and specifically into lungs. Gold and dendritic NPs are conjugated to aminopeptidase-P2 antibodies targeting caveolae of lung microvascular endothelium. SPECT-CT imaging and biodistribution analyses reveal that rat lungs extract most of the intravenously injected dose within minutes to achieve rapid blood clearance, high lung tissue concentrations well beyond peak blood levels, and precision lung imaging and targeting. Active transcytosis by caveolae greatly outperforms passive transvascular delivery and can even outpace RES scavenging. These results reveal how much ECs can both limit and promote tissue penetration of NPs and the power and limitations of the CPS. This study provides a new retargeting paradigm for small NPs to avoid RES uptake and achieve unprecedented rapid precision nanodelivery for future diagnostic and therapeutic applications.

Bioengineering

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: How to achieve rapid and precise delivery to the lungs by optimizing the size of nanoparticles (NPs) and targeting strategies and utilizing the caveolae pumping system (CPS) in endothelial cells, thereby increasing the concentration of drugs and imaging agents in the target tissue and avoiding rapid clearance by the reticuloendothelial system (RES).

Specifically, the researchers are concerned with:
1. **The influence of NP size**: Whether nanoparticles of different sizes can effectively enter the caveolae in the lungs and efficiently cross the endothelial barrier into the lung tissue through its pumping mechanism.
2. **The role of targeting antibodies**: Whether the use of specific targeting antibodies (such as mAPP2) can significantly change the biodistribution of nanoparticles, making them more concentrated in the lungs rather than being captured by the RES.
3. **The competition between CPS and RES**: To explore whether CPS can, when the NP size is appropriate, extract and transport NPs from the blood to the lungs more effectively than RES.

Through these studies, the authors hope to reveal the potential of the caveolae pumping system in endothelial cells in nanoparticle delivery and provide new ideas and technical means for future diagnostic and treatment applications. This research aims to overcome the main challenges in existing nanocarrier delivery systems, that is, how to avoid rapid clearance by RES and achieve efficient targeted delivery to non - RES tissues (such as the lungs).

### Key problem summary
- **The relationship between NP size and CPS**: Determine nanoparticles within the optimal size range so that they can efficiently utilize the caveolae pumping system for trans - endothelial transport.
- **The effectiveness of targeting antibodies**: Verify whether specific antibodies (such as mAPP2) can significantly enhance the accumulation of NPs in the lungs while reducing the aggregation in other organs (such as the liver and spleen).
- **CPS vs RES**: Evaluate the relative efficiency of CPS and RES in NP extraction and transport, especially the performance differences under different NP sizes.

The answers to these questions will contribute to the development of more effective nanodrug delivery systems, especially for the treatment of diseases that require high - precision targeting.